Lisbon, October 4, 2023, In Lisbon, Minister of Economy and Planning, Faisal bin Fadel Al-Ibrahim, representing the Chairman of the Saudi Food and Drug Authority (SFDA), signed a memorandum of understanding (MoU) with the National Authority of Medicines and Health Products in Portugal during the sixth session of the Saudi-Portuguese Joint Committee.
The MoU's primary objective is to strengthen collaboration and the exchange of information and expertise between the two regulatory bodies. It specifically focuses on the regulation of medicines, medical devices, cosmetic products, and related areas like laboratories and inspection.
Under this agreement, both parties will share experiences, information, engage in technical visits, and establish on-the-job training programs. These activities will encompass various aspects of regulatory work, including laboratory tests for biological preparations, evaluation of similar preparations (covering manufacturing and chemical control), assessment of bioequivalence studies, conducting clinical trials and maintaining good clinical practice (GCP) standards. Additionally, the MoU covers tests related to the safety and effectiveness of medical devices and supplies for licensing, marketing, and post-marketing control purposes.
